(Q51963389)

English

Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2.

scientific article published on 9 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

1 reference

based on heuristic

inferred from title

Inge Marie Svane

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

Anders Elm Pedersen

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

author name string

Kirsten Nikolajsen

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

Mai-Britt Zocca

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

language of work or name

0 references

publication date

9 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

26

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

36

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

4716-4724

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Identification and design of p53-derived HLA-A2-binding peptides with increased CTL immunogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Progressive differentiation and selection of the fittest in the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Adoptive immunotherapy for cancer: building on success

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Regulatory T lymphocytes: pivotal components of the host antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Immune monitoring of T-cell responses in cancer vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Seventeen-colour flow cytometry: unravelling the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Predicting tumor outcome following cancer vaccination by monitoring quantitative and qualitative CD8+ T cell parameters.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

CD8+ T-cell memory in tumor immunology and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Quiescent phenotype of tumor-specific CD8+ T cells following immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Status of activation of circulating vaccine-elicited CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Melanoma vaccines: the paradox of T cell activation without clinical response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Immunodeficiency and cancer: prospects for correction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Recent thymic output function in patients with hematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Regulatory T cells, tumour immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Dendritic cell-regulatory T-cell interactions control self-directed immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

CD28-mediated co-stimulation: a quantitative support for TCR signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Effector T Cell Pool

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

CD27 is required for generation and long-term maintenance of T cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.085

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.06.085

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18616968

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51963389&oldid=1790332236"